Head-to-head · Value Score
Vitara RX vs NovoCare Pharmacy
Two GLP-1 deals, scored on the same six factors. Vitara RX lands a Value Score of 91, NovoCare Pharmacy a 75. Here's who gives you the honest lower price — and where each one bites back.
Vitara RX
#4 · Grade A · Best Value
Est. first month
$99/mo
Save ~93% vs brand-nameNovoCare Pharmacy
#134 · Grade C+ · Fair Price
Est. first month
From $149/mo (brand Wegovy, compounded oral)
Save ~89% vs brand-nameThe verdict
Vitara RX takes it on Value Score, 91 to 75 — an est. $99/mo first month, with no teaser step-up baked in. NovoCare Pharmacy isn't out of it: Shoppers who want branded Wegovy at the lowest manufacturer-direct self-pay price.
Deal-by-deal
The numbers that decide it. Green ✓ marks the stronger side on each line.
| Deal | Vitara RX | NovoCare Pharmacy |
|---|---|---|
| Value Score | 91 (A) | 75 (C+) |
| Est. first month | $99/mo | From $149/mo (brand Wegovy, compounded oral) |
| Save vs brand-name | ~93% | ~89% |
| Semaglutide | $99/mo | From $149/mo (brand Wegovy, compounded oral) |
| Tirzepatide | $149/mo | Not disclosed |
| Both molecules | Yes | No |
| Pricing | Flat — no step-up | Watch |
| Coverage | 49 states | All 50 states |
Factor by factor
The six factors behind each Value Score. The orange bar marks the stronger side. See the methodology.
Vitara RX
VitaraRx is a direct-to-consumer telehealth marketplace offering compounded semaglutide and tirzepatide at flat per-drug pricing across all doses — no membership or hidden fees.
Why it's a deal
- Among the lowest flat pricing in the market — $99/mo semaglutide and $149/mo tirzepatide, all doses same price
- Names its 503A pharmacy partner (Manifest Pharmacy, Greer SC) — strong supply-chain transparency
- LegitScript Certified
- Publishes the FDA compounded-medication disclaimer
- Covers 49 states with an explicit state list, not vague "most states" language
The fine print
- No corporate legal entity disclosed — only the trade name "VitaraRx"
- No named medical director — all clinical decisions made by independent providers (marketplace model)
- All sales final — no medication returns
- Per-vial mg quantity isn't clearly disclosed, making price comparisons harder
- Doesn't ship to Alaska
NovoCare Pharmacy
Novo Nordisk's first-party direct-to-consumer pharmacy for branded Wegovy (semaglutide).
Why it's a deal
- First-party Novo Nordisk pharmacy — the most authoritative branded Wegovy channel
- $199/mo intro pricing on Wegovy 0.25/0.5 mg starter doses (through 6/30/2026), the lowest brand self-pay price
- $349/mo standard self-pay is well below the ~$1,300/mo retail list price
- Ships to all 50 states with no telehealth-platform middleman fees
- Cold-chain logistics handled directly by Novo Nordisk
The fine print
- Wegovy only — no Ozempic, no tirzepatide, no compounded GLP-1
- Requires an existing Wegovy prescription — no prescribing clinicians or telehealth intake
- No clinical support included — your own prescriber handles titration and side effects
- Manufacturer-set pricing can change at any time
- $199 pen intro covers only the first 2 fills for new patients (through 6/30/2026); maintenance doses are $349/mo ($399 HD)
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes a Value Score.
Neither one the right fit? Every program that outscores Vitara RX is ranked on the Vitara RX alternatives board, and the same list for the other side is on alternatives to NovoCare Pharmacy.
More head-to-heads
Prices, states and verification reflect each program's public disclosures at last check; the Value Score is our editorial judgment per the methodology. “Save vs brand-name” compares the lowest disclosed monthly price against a ~$1,349/mo brand-name cash reference. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.